Rossari Biotech DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.76×	0.74×	0.74×	0.74×	0.75×
	0.94×	0.97×	0.93×	0.94×	0.89×
	8.1%	8.6%	9.5%	10.3%	9.7%
	1.15×	1.15×	1.20×	1.25×	1.26×
	1.68×	1.72×	1.60×	1.50×	1.49×
	11.1%	12.3%	12.6%	13.4%	12.2%
	11.9%	11.9%	12.2%	13.3%	12.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ROSSARI₹407.60

Rossari Biotech Limited

· Chemicals

₹ CrorePeersNOCIL HSCL NAVINFLUOR DDEVPLSTIK CHEMPLASTS TATACHEM AARTIIND JGCHEMMcap ₹2,257 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.74	0.74	0.74	0.76
Interest Burden (Pretax/EBIT) ×	0.89	0.94	0.93	0.97	0.94
EBIT Margin %	9.67	10.34	9.52	8.63	8.07
Asset Turnover ×	1.26	1.25	1.20	1.15	1.15
Financial Leverage (Assets/Equity) ×	1.49	1.50	1.60	1.72	1.68
ROE (5-step product, year-end total equity) %	12.20	13.39	12.58	12.29	11.06
ROE (owners' profit / average owners' equity) %	12.47	13.32	12.21	11.85	11.85

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.